Erectile Dysfunction Treatment Using Focused Linear Low-Intensity Extracorporeal Shockwaves: Single-Blind, Sham-Controlled, Randomized Clinical Trial
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F20%3A10412744" target="_blank" >RIV/00216208:11110/20:10412744 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216224:14110/20:00115341 RIV/65269705:_____/20:00071733 RIV/00159816:_____/20:00071733 RIV/00064165:_____/20:10412744
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=CaQlNsdP4g" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=CaQlNsdP4g</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1159/000504788" target="_blank" >10.1159/000504788</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Erectile Dysfunction Treatment Using Focused Linear Low-Intensity Extracorporeal Shockwaves: Single-Blind, Sham-Controlled, Randomized Clinical Trial
Popis výsledku v původním jazyce
Introduction:Low-intensity extracorporeal shock wave therapy (Li-ESWT) is a new treatment modality for erectile dysfunction (ED). Our aim was to evaluate the treatment outcome of Li-ESWT for ED in single-blind, placebo controlled, randomized clinical trial.Methods:Sixty patients were randomized into 2 age-matched groups: Group A - treatment and Group B - placebo. Treatment consisted of 4 sessions on the PiezoWave2 unit (R. Wolf and ELvation Medical). Effectiveness was assessed according to the International Index of Erectile Function 5 (IIEF-5), Erectile Hardness Score (EHS), questions 2 and 3 of the Sexual Encounter Profile (SEP 2, SEP 3), and Global Assessment Question (GAQ) scores at baseline and 4 and 12 weeks after treatment. We evaluated patient's and partner's subjective satisfaction.Results:A statistically significant difference between the groups was found at 4 and 12 weeks after treatment with regard to the quality of erection as measured by the IIEF-5 (p= 0.049 andp< 0.001, respectively), the EHS after week 12 (p< 0.001), an increase in the EHS after 4 and 12 weeks (p= 0.030 andp< 0.001, respectively), after 12 weeks in GAQ (p< 0.001), SEP 2 (p= 0.05), SEP 3 (p< 0.001), and patient's satisfaction (p< 0.001) and partner's satisfaction (p< 0.001).Conclusions:The randomized single-blind study confirms that Li-ESWT significantly improves erectile function.
Název v anglickém jazyce
Erectile Dysfunction Treatment Using Focused Linear Low-Intensity Extracorporeal Shockwaves: Single-Blind, Sham-Controlled, Randomized Clinical Trial
Popis výsledku anglicky
Introduction:Low-intensity extracorporeal shock wave therapy (Li-ESWT) is a new treatment modality for erectile dysfunction (ED). Our aim was to evaluate the treatment outcome of Li-ESWT for ED in single-blind, placebo controlled, randomized clinical trial.Methods:Sixty patients were randomized into 2 age-matched groups: Group A - treatment and Group B - placebo. Treatment consisted of 4 sessions on the PiezoWave2 unit (R. Wolf and ELvation Medical). Effectiveness was assessed according to the International Index of Erectile Function 5 (IIEF-5), Erectile Hardness Score (EHS), questions 2 and 3 of the Sexual Encounter Profile (SEP 2, SEP 3), and Global Assessment Question (GAQ) scores at baseline and 4 and 12 weeks after treatment. We evaluated patient's and partner's subjective satisfaction.Results:A statistically significant difference between the groups was found at 4 and 12 weeks after treatment with regard to the quality of erection as measured by the IIEF-5 (p= 0.049 andp< 0.001, respectively), the EHS after week 12 (p< 0.001), an increase in the EHS after 4 and 12 weeks (p= 0.030 andp< 0.001, respectively), after 12 weeks in GAQ (p< 0.001), SEP 2 (p= 0.05), SEP 3 (p< 0.001), and patient's satisfaction (p< 0.001) and partner's satisfaction (p< 0.001).Conclusions:The randomized single-blind study confirms that Li-ESWT significantly improves erectile function.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30217 - Urology and nephrology
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Urologia Internationalis
ISSN
0042-1138
e-ISSN
—
Svazek periodika
104
Číslo periodika v rámci svazku
5-6
Stát vydavatele periodika
CH - Švýcarská konfederace
Počet stran výsledku
8
Strana od-do
417-424
Kód UT WoS článku
000543544500014
EID výsledku v databázi Scopus
2-s2.0-85076703161